Navigo Proteins GmbH

Trending Articles

  1. Novartis' Kisqali plus ET bags FDA approval for HR+/HER2- breast cancer The decision comes off the back of the Phase III NATALEE clinical trial, which diminished the risk of disease recurrence by 25.1%
  2. Formulated Solutions expands aerosol production capabilities with fully automated line The fully automated line will help serve the growing demand for pharmaceutical packaging in the US and further afield
  3. RSSL opens 3D imaging and metrology laboratory for end-to-end research and analysis The laboratory will offer, micro-CT, microscopy and spectroscopy services for its pharmaceutical and medical device partners
  4. AstraZeneca opens a 'people hub' at its Macclesfield site The energy-efficient building will offer AZ employees a collaborative space
  5. TekniPlex Healthcare to showcase concept-to-commercialisation capabilities at MD&M Minneapolis The company will emphasise expanded capabilities for class III implantable devices and delivery systems

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Research & Development

Navigo Proteins announces extension of partnership with ITM

Through the partnership, the company is developing targeted radiopharmaceutical candidates for the treatment of cancer
Subscribe now